HIV - AIGHD - Page 6

14 Jun Register now! Seminar Monday 20 June, Tuberculosis and HIV: clinical and epidemiological research in South Africa

Posted at 11:05h in News

This is to remind you of the following seminar on the occasion of the PhD defense of Andrew Kerkhoff, that AIGHD hosts together with the AMC Department of Tropical Medicine. Please register at the latest on Wednesday June 15 (secretariat@aighd.org). Kind regards, Prof. Frank Cobelens and...

28 Mar HIV researcher Peter Reiss, Co-Chair for AIDS 2018 promotes Amsterdam as innovative city

Posted at 14:07h in News

The 22nd International AIDS Conference (AIDS 2018) will be held on 22-28 July 2018 in Amsterdam, the Netherlands at the Amsterdam RAI and is expected to bring together some 18,000 participants from around the world. The AIDS Conference is the largest conference on any global health or development issue....

25 Feb Modern HIV prevention for Women

Posted at 22:25h in News

Cate Hankins, member of the organizing committee for the HIV and Women Workshop held in Boston on February 20-21, chaired an exciting session on biomedical HIV prevention for women, contraception and HIV, and multipurpose technologies for women. “What’s next for women?” was the question on...

01 Feb HIV resistance to tenofovir

Posted at 21:33h in News, Publications

Potent tenofovir-containing antiretroviral regimens are increasingly used to treat and prevent HIV. Few data exist on the frequency of and risk factors for acquired drug resistance in regions hardest hit by the HIV pandemic. This collaborative study combined data from adult treatment cohorts and clinical...

26 Nov Amsterdam HIV Testing Week 28/11 – 4/12

Posted at 14:57h in News

The goal of the Amsterdam HIV Testing Week is to make more people aware of their HIV status and encourage people who could be at risk of HIV to get a test. GGD Amsterdam and a few GGD’s in other cities, general practitioners, hospitals and...

05 Aug Long-term suppression of HIV in LMICs

Posted at 10:43h in News, Publications

Viral suppression is the cornerstone of success in long-term HIV treatment. The World Health Organization commissioned us to systematically review the scientific literature on HIV treatment outcomes. We focused on the viral loads of adults on first-line antiretroviral therapy for HIV-1 in low- and middle-income...

05 Aug Pre-treatment HIV drug resistance

Posted at 10:13h in News, Publications

With the progressive scale-up of antiretroviral therapy in Africa, pre-treatment drug resistance is increasing. People who have never been on treatment are found to harbour drug resistant HIV even before they start first-line antiretroviral therapy. In the PanAfrican Studies to Evaluate Resistance (PASER) cohort, a...

05 Aug Deciding about PrEP for HIV prevention

Posted at 09:54h in News, Publications

Antiretroviral drugs are proven to prevent people from acquiring HIV. The effectiveness of this pre-exposure prophylaxis (PrEP) in clinical trials now is being put to the test in real world settings, with excellent results presented at the recent AIDS 2015 conference in Vancouver. This paper...

05 Jun Worldwide trends in Transmitted HIV-1 Dr

Posted at 16:15h in News, Publications

The global scale-up of antiretroviral therapy (ART) has reduced AIDS deaths and HIV incidence, but drug resistance is threatening these advances. This meta-analysis combined data from 50,870 patients in 287 studies between 2000 and 2013. It found that the average overall prevalence of transmitted drug...

29 Sep More comorbidity in those aging with HIV

Posted at 13:49h in News, Publications

HIV-infected individuals may be at increased risk of age-associated comorbidity. The AGEhIV Cohort Study investigates prevalence, incidence and risk factors for age-associated comorbidity among HIV-1-infected (n=598) and highly comparable HIV-uninfected individuals (n=550), all aged 45 and above. Baseline (cross-sectional) results from the AGEhIV Cohort Study...

Search